Clinical trials: Pseudophakia
Pseudophakia
Visual Outcomes and Patient Satisfaction With Bilateral PanOptix Verses Bilateral Synergy
Background: The Tecnis Synergy intraocular lens (IOL) has a claim to allow patients to experience continuous high-contrast vision from far through near even in low-light conditions.
- Trial name
- NCT06041139
- Testing
- Visual Acuity, Defocus Curve, Halo and Glare testing
- Where
- United States
- Volunteers
- 230 people, healthy volunteers welcome
- Sponsor
- Berkeley Eye Center
Presbyopia, Pseudophakia
Synergy Lens Outcomes Evaluation
This is a single visit study to evaluate the visual outcomes and patient satisfaction of patients who were bilaterally implanted with the Tecnis Synergy IOL between June 1 and December 31, 2021 in 2 centers in USA
- Trial name
- NCT05418153
- Testing
- Tecnis Synergy IOL
- Where
- 2 sites in United States
- Volunteers
- 52 people
- Sponsor
- Center For Sight
Capsule Opacification, Pseudophakia
Posterior Capsule Opacification and Frequency of Nd:YAG Treatment and of Two Microincision IOLs: Hoya iMics NY-60 vs Acrysof SN60WF
Age-related cataract is the main cause of impaired vision in the elderly population worldwide. In the UK, more than half of people who are over 65 have some cataract development in one or both eyes.
- Conditions
- Capsule Opacification, Pseudophakia, Cataract
- Trial name
- NCT01732484
- Testing
- intraocular lens implantation
- Volunteers
- 100 people
- Sponsor
- Medical University of Vienna
Inflammation, Pseudophakia
Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1%
This is a single-center, randomized, investigator-masked, parallel group, and active-comparator controlled study investigating the clinical outcomes for visual acuity and macular thickness after treatment with Bromday (bromfenac…
- Trial name
- NCT01310127
- Testing
- Bromfenac, Nepafenac
- Volunteers
- 23 people
- Sponsor
- Toyos Clinic
Dry Eye Syndromes
The Effects of BAK on the Blood Aqueous Barrier of Pseudophakic Patients
BAK is one of the most frequent preservatives in eye drops. BAK is a quaternary ammonium salt with surfactant qualities. It can be bacteriostatic or bactericidal depending on the concentrations used.
- Trial name
- NCT01280110
- Testing
- Hydroxypropylmethylcellulose, Carboxymethylcellulose
- Where
- Brazil
- Volunteers
- 44 people, healthy volunteers welcome
- Sponsor
- University of Campinas, Brazil
Pseudophakia, Inflammation
Clinical Outcomes and Evaluation of Lotemax 0.5% in Treatment of Ocular Inflammation Associated With Cataract Surgery
Investigate the intraocular pressure(pressure inside the eye) of patients who are treated with Lotemax after undergoing cataract surgery.
- Trial name
- NCT01344226
- Testing
- loteprednol 0.5% ophthalmic solution
- Where
- United States
- Volunteers
- 49 people
- Sponsor
- Toyos Clinic
Pseudophakia
Visual Outcomes and Patient Satisfaction With Vivity IOL in Post Refractive Patients
This is a non-interventional, prospective, observational study of the outcomes for post myopic refractive surgery patients following successful, uncomplicated cataract surgery with bilateral implantation of the Vivity IOL…
- Trial name
- NCT06064916
- Testing
- Visual Acuity, Defocus Curve, Intraocular Lens Satisfaction (IOLSAT) Questionnaire
- Where
- United States
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- Berkeley Eye Center
Pseudophakia
The Effects of Angle Kappa on Clinical Outcomes With the PanOptix Intraocular Lens
Angle Kappa is considered a potential factor in explaining suboptimal outcomes with intraocular lenses (IOLs), particularly multifocal IOLs. Some evidence suggests this is not the case.
- Trial name
- NCT04242875
- Testing
- Angle Kappa, Visual disturbance questionnaire.
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Carolina Eyecare Physicians, LLC
Pseudophakia
Maximizing Visual Outcomes With Eyhance IOLs
This is a non-interventional prospective, single center, bilateral, non-randomized, open-label, observational clinical study. All patients will have had bilateral implantation of an Eyhance IOL at the time of cataract surgery.
- Trial name
- NCT05611073
- Testing
- Visual Acuity, Biometric Data Collection, Patient Questionnaire
- Where
- United States
- Volunteers
- 110 people, healthy volunteers welcome
- Sponsor
- Berkeley Eye Center
Pseudophakia
Intermediate Vision in Patients With Clareon IOLs Compared to Eyhance IOLs
Compare visual outcomes in patients with bilateral Clareon Monofocal IOLs versus bilateral Eyhance IOLs.
- Trial name
- NCT05226884
- Testing
- Visual Acuity, Defocus Curve
- Where
- United States
- Volunteers
- 310 people, healthy volunteers welcome
- Sponsor
- Berkeley Eye Center
Pseudophakia
Corrected VA With Long-Term Follow-Up After AcrySof® Intraocular Lens (IOL) Implantation
The purpose of this study is to compare the long-term visual acuity (VA) with an acrylic IOL to a silicone or polymethylmethacrylate (PMMA) IOL in cataract patients. This study will take place in Japan.
- Trial name
- NCT02450799
- Testing
- Acrylic IOL, Silicone IOL, PMMA IOL
- Volunteers
- 104 people
- Sponsor
- Alcon, a Novartis Company